These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28367091)

  • 1. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
    Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
    Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
    Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
    Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
    Dewald JH; Cavdarli S; Steenackers A; Delannoy CP; Mortuaire M; Spriet C; Noël M; Groux-Degroote S; Delannoy P
    PLoS One; 2018; 13(4):e0196369. PubMed ID: 29698439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
    Battula VL; Nguyen K; Sun J; Pitner MK; Yuan B; Bartholomeusz C; Hail N; Andreeff M
    Oncotarget; 2017 Jun; 8(23):36936-36949. PubMed ID: 28415808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.
    Sarkar TR; Battula VL; Werden SJ; Vijay GV; Ramirez-Peña EQ; Taube JH; Chang JT; Miura N; Porter W; Sphyris N; Andreeff M; Mani SA
    Oncogene; 2015 Jun; 34(23):2958-67. PubMed ID: 25109336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase.
    Cazet A; Bobowski M; Rombouts Y; Lefebvre J; Steenackers A; Popa I; Guérardel Y; Le Bourhis X; Tulasne D; Delannoy P
    Glycobiology; 2012 Jun; 22(6):806-16. PubMed ID: 22301273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside GD3 synthase (GD3S), a novel cancer drug target.
    Liu J; Zheng X; Pang X; Li L; Wang J; Yang C; Du G
    Acta Pharm Sin B; 2018 Sep; 8(5):713-720. PubMed ID: 30245960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
    Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
    J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of expression and prognostic implications of GD2 and GD3 synthase in canine histiocytic sarcoma.
    Murphy JD; Axiak-Bechtel S; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Shiomitsu K
    Vet Immunol Immunopathol; 2023 May; 259():110594. PubMed ID: 37058951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GD₃ synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activation.
    Cazet A; Lefebvre J; Adriaenssens E; Julien S; Bobowski M; Grigoriadis A; Tutt A; Tulasne D; Le Bourhis X; Delannoy P
    Mol Cancer Res; 2010 Nov; 8(11):1526-35. PubMed ID: 20889649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
    Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
    Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3.
    Shibuya H; Hamamura K; Hotta H; Matsumoto Y; Nishida Y; Hattori H; Furukawa K; Ueda M; Furukawa K
    Cancer Sci; 2012 Sep; 103(9):1656-64. PubMed ID: 22632091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.
    Liang YJ
    Glycoconj J; 2022 Apr; 39(2):177-195. PubMed ID: 35267131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.
    Hashimoto N; Ito S; Tsuchida A; Bhuiyan RH; Okajima T; Yamamoto A; Furukawa K; Ohmi Y; Furukawa K
    J Biol Chem; 2019 Jul; 294(28):10833-10845. PubMed ID: 31138648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model.
    Ohkawa Y; Zhang P; Momota H; Kato A; Hashimoto N; Ohmi Y; Bhuiyan RH; Farhana Y; Natsume A; Wakabayashi T; Furukawa K; Furukawa K
    Cancer Sci; 2021 Sep; 112(9):3756-3768. PubMed ID: 34145699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells.
    Ruan S; Raj BK; Lloyd KO
    J Neurochem; 1999 Feb; 72(2):514-21. PubMed ID: 9930722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.
    Cao S; Hu X; Ren S; Wang Y; Shao Y; Wu K; Yang Z; Yang W; He G; Li X
    Front Cell Dev Biol; 2023; 11():1076862. PubMed ID: 36824365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GM2 mediates migration of tumor cells by interacting with integrin and modulating the downstream signaling pathway.
    Kundu M; Mahata B; Banerjee A; Chakraborty S; Debnath S; Ray SS; Ghosh Z; Biswas K
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1472-89. PubMed ID: 27066976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells.
    Cazet A; Groux-Degroote S; Teylaert B; Kwon KM; Lehoux S; Slomianny C; Kim CH; Le Bourhis X; Delannoy P
    Biol Chem; 2009 Jul; 390(7):601-9. PubMed ID: 19335207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.